| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.25 | 0.1 |